121 related articles for article (PubMed ID: 6183555)
1. Inhibitors binding to L-aromatic amino acid decarboxylase.
Barboni E; Voltattorni CB; D'Erme M; Fiori A; Minelli A; Rosei MA
Life Sci; 1982 Oct; 31(14):1519-24. PubMed ID: 6183555
[TBL] [Abstract][Full Text] [Related]
2. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
Tancini B; Dominici P; Simmaco M; Schininà ME; Barra D; Voltattorni CB
Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
[TBL] [Abstract][Full Text] [Related]
3. Rat liver aromatic L-amino acid decarboxylase: spectroscopic and kinetic analysis of the coenzyme and reaction intermediates.
Hayashi H; Mizuguchi H; Kagamiyama H
Biochemistry; 1993 Jan; 32(3):812-8. PubMed ID: 8422386
[TBL] [Abstract][Full Text] [Related]
4. Functionally important residues of aromatic L-amino acid decarboxylase probed by sequence alignment and site-directed mutagenesis.
Ishii S; Mizuguchi H; Nishino J; Hayashi H; Kagamiyama H
J Biochem; 1996 Aug; 120(2):369-76. PubMed ID: 8889823
[TBL] [Abstract][Full Text] [Related]
5. Transition-state analogues as inhibitors of L-dopa decarboxylase.
Brinkworth RI; Iles MM; Iskander MN; Andrews PR
Int J Biochem; 1988; 20(11):1273-9. PubMed ID: 3248681
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxal 5'-phosphate deficiency causes a loss of aromatic L-amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic L-amino acid decarboxylase and vitamin B(6) deficiency states.
Allen GF; Neergheen V; Oppenheim M; Fitzgerald JC; Footitt E; Hyland K; Clayton PT; Land JM; Heales SJ
J Neurochem; 2010 Jul; 114(1):87-96. PubMed ID: 20403077
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Dopa decarboxylase by caffeic acid and related compounds: structure-activity relationships.
Rosei MA
Pharmacol Res Commun; 1987 Oct; 19(10):663-71. PubMed ID: 3441482
[TBL] [Abstract][Full Text] [Related]
8. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
Tancini B; Dominici P; Barra D; Voltattorni CB
Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
[TBL] [Abstract][Full Text] [Related]
9. Multiple evolutionary origin of pyridoxal-5'-phosphate-dependent amino acid decarboxylases.
Sandmeier E; Hale TI; Christen P
Eur J Biochem; 1994 May; 221(3):997-1002. PubMed ID: 8181483
[TBL] [Abstract][Full Text] [Related]
10. Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets.
Lindström P
Biochim Biophys Acta; 1986 Nov; 884(2):276-81. PubMed ID: 3533158
[TBL] [Abstract][Full Text] [Related]
11. Transaldimination induces coenzyme reorientation in pig kidney dopa decarboxylase.
Moore PS; Dominici P; Voltattorni CB
Biochimie; 1995; 77(9):724-28. PubMed ID: 8789463
[TBL] [Abstract][Full Text] [Related]
12. Sanguinarine and chelerythrine as inhibitors of aromatic amino acid decarboxylase.
Drsata J; Ulrichová J; Walterová D
J Enzyme Inhib; 1996; 10(4):231-237. PubMed ID: 8872743
[TBL] [Abstract][Full Text] [Related]
13. Pig kidney dopa decarboxylase. Structure and function.
Dominici P; Filipponi P; Schininà ME; Barra D; Borri Voltattorni C
Ann N Y Acad Sci; 1990; 585():162-72. PubMed ID: 2162642
[No Abstract] [Full Text] [Related]
14. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
Bertoldi M; Borri Voltattorni C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
[TBL] [Abstract][Full Text] [Related]
15. Instability of the apo form of aromatic L-amino acid decarboxylase in vivo and in vitro: implications for the involvement of the flexible loop that covers the active site.
Matsuda N; Hayashi H; Miyatake S; Kuroiwa T; Kagamiyama H
J Biochem; 2004 Jan; 135(1):33-42. PubMed ID: 14999007
[TBL] [Abstract][Full Text] [Related]
16. Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase. Effects on catalytic properties.
Bertoldi M; Castellani S; Bori Voltattorni C
Eur J Biochem; 2001 May; 268(10):2975-81. PubMed ID: 11358515
[TBL] [Abstract][Full Text] [Related]
17. Simple purification of aromatic L-amino acid decarboxylase from human pheochromocytoma using high-performance liquid chromatography.
Ichinose H; Kojima K; Togari A; Kato Y; Parvez S; Parvez H; Nagatsu T
Anal Biochem; 1985 Nov; 150(2):408-14. PubMed ID: 4091266
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat.
Bouchard S; Bousquet C; Roberge AG
J Neurochem; 1981 Sep; 37(3):781-7. PubMed ID: 6974228
[No Abstract] [Full Text] [Related]
19. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
[TBL] [Abstract][Full Text] [Related]
20. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
